Infographics on risks associated with COVID-19 and the willingness to get the AstraZeneca vaccine: two randomized online experiments
Abstract Background Germans hesitated to get vaccinated with AstraZeneca in the COVID-19 pandemic after reports of blood clots. Methods In two preregistered online experiments with stratified randomization (Study 1 N = 824, Study 2: N = 1,056), we tested whether providing evidence-based benefit-risk...
Saved in:
Main Authors: | Lisa Felgendreff (Author), Regina Siegers (Author), Leonie Otten (Author), Cornelia Betsch (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Busting the Breast Cancer with AstraZeneca's Gefitinib
by: S. Chemmalar, et al.
Published: (2023) -
Lipschütz ulcers after AstraZeneca COVID-19 vaccination
by: Maria Bracho-Borro, et al.
Published: (2023) -
New-onset bullous pemphigoid triggered by AstraZeneca COVID-19 vaccine
by: Yin-Cheng Chao, et al.
Published: (2022) -
[Translated article] Lipschütz Ulcers After the AstraZeneca COVID-19 Vaccine
by: N. González-Romero, et al.
Published: (2022) -
Rhabdomyolysis following Oxford/AstraZeneca COVID-19 vaccination; two case reports from Iran
by: Marzieh Hashemi, et al.
Published: (2024)